FDA Import Refusal SCS-5405877-2/11/2 — Novo Nordisk A/S
The FDA refused shipment SCS-5405877-2/11/2 from Novo Nordisk A/S (Denmark) on June 27, 2019. The refused product falls under Drugs and Biologics — INSULIN HUMAN/INSULIN SUSP ISOPHANE HUMA (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 27, 2019
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY35 INSULIN HUMAN/INSULIN SUSP ISOPHANE HUMA (ANTI-DIABETIC)
- Charges
- 75